Prometheon Pharma, LLC - Product Pipeline Review - 2016

  • ID: 3972703
  • Company Profile
  • 32 pages
  • Global Markets Direct
1 of 4
Prometheon Pharma, LLC - Product Pipeline Review - 2016

‘Prometheon Pharma, LLC - Product Pipeline Review - 2016’, provides an overview of the Prometheon Pharma, LLC’s pharmaceutical research and development focus.

The report provides comprehensive information on the therapeutics under development by Prometheon Pharma, LLC, complete with analysis by stage of development, drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. The report also covers the descriptive pharmacological action of the therapeutics, its complete research and development history and the dormant and discontinued projects.

This report features investigational drugs from across globe covering over 20 therapy areas and nearly 3,000 indications. The report is built using data and information sourced from databases, company/university websites, clinical trial registries, conferences, SEC filings, investor presentations and featured press releases from company/university sites and industry-specific third party sources. Drug profiles featured in the report undergoes periodic review following a stringent set of processes to ensure that all the profiles are updated with the latest set of information. Additionally, various dynamic tracking processes ensure that the most recent developments are captured on a real time basis.

The report helps in identifying and tracking emerging players in the market and their portfolios, enhances decision making capabilities and helps to create effective counter strategies to gain competitive advantage.

Note - : Certain sections in the report may be removed or altered based on the availability and relevance of data.

Scope:

- The report provides a snapshot of the pipeline therapeutic landscape of Prometheon Pharma, LLC
- The report provides overview of Prometheon Pharma, LLC including its business description, key facts, and locations and subsidiaries
- The report features descriptive drug profiles for the pipeline products which includes, product description, descriptive MoA, R&D brief, licensing and collaboration details & other developmental activities
- The report covers pipeline products based on various stages of development ranging from pre-registration till discovery and undisclosed stages
- The report assesses Prometheon Pharma, LLC’s pipeline therapeutics based on drug target, mechanism of action (MoA), route of administration (RoA) and molecule type
- The report features Prometheon Pharma, LLC’s out-licensed and partnered product portfolio and summarizes its dormant and discontinued projects

Reasons to Buy:

- Evaluate Prometheon Pharma, LLC’s strategic position with total access to detailed information on its product pipeline
- Gain strategically significant competitor information, analysis, and insights to formulate effective R&D strategies
- Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
- Identify and understand important and diverse types of therapeutics under development for Prometheon Pharma, LLC
- Identify potential new clients or partners in the target demographic
- Plan mergers and acquisitions effectively by identifying key players and it’s most promising pipeline therapeutics
- Devise corrective measures for pipeline projects by understanding Prometheon Pharma, LLC’s pipeline depth and focus of pipeline therapeutics
- Develop and design in-licensing and out-licensing strategies by identifying prospective partners with the most attractive projects to enhance and expand business potential and scope
READ MORE
Note: Product cover images may vary from those shown
2 of 4
Prometheon Pharma, LLC Snapshot

Prometheon Pharma, LLC Overview

Key Facts

Prometheon Pharma, LLC - Research and Development Overview

Key Therapeutic Areas

Prometheon Pharma, LLC - Pipeline Review

Pipeline Products by Stage of Development

Pipeline Products - Monotherapy

Pipeline Products - Combination Treatment Modalities

Prometheon Pharma, LLC - Pipeline Products Glance

Prometheon Pharma, LLC - Early Stage Pipeline Products

Preclinical Products/Combination Treatment Modalities

Discovery Products/Combination Treatment Modalities

Prometheon Pharma, LLC - Drug Profiles

(measles + mumps + rubella) vaccine - Drug Profile

Product Description

Mechanism Of Action

R&D Progress

diphtheria vaccine - Drug Profile

Product Description

Mechanism Of Action

R&D Progress

Drug to Agonize GLP-1 for Type I and Type II Diabetes - Drug Profile

Product Description

Mechanism Of Action

R&D Progress

Drug to Inhibit DPP-1 for Type I and Type II Diabetes - Drug Profile

Product Description

Mechanism Of Action

R&D Progress

Drug to Inhibit SGLT-2 for Type I and Type II Diabetes - Drug Profile

Product Description

Mechanism Of Action

R&D Progress

insulin human - Drug Profile

Product Description

Mechanism Of Action

R&D Progress

pneumococcal vaccine - Drug Profile

Product Description

Mechanism Of Action

R&D Progress

Protein to Agonize Insulin Like Growth Factor 1 Receptor for Hormone Replacement Therapy - Drug Profile

Product Description

Mechanism Of Action

R&D Progress

sertraline hydrochloride - Drug Profile

Product Description

Mechanism Of Action

R&D Progress

Small Molecules to Inhibit TRIP-Br2 for Obesity and Insulin Resistance - Drug Profile

Product Description

Mechanism Of Action

R&D Progress

somatropin - Drug Profile

Product Description

Mechanism Of Action

R&D Progress

tetanus vaccine - Drug Profile

Product Description

Mechanism Of Action

R&D Progress

Prometheon Pharma, LLC - Pipeline Analysis

Prometheon Pharma, LLC - Pipeline Products by Target

Prometheon Pharma, LLC - Pipeline Products by Route of Administration

Prometheon Pharma, LLC - Pipeline Products by Molecule Type

Prometheon Pharma, LLC - Pipeline Products by Mechanism of Action

Prometheon Pharma, LLC - Locations And Subsidiaries

Head Office

Appendix

Methodology

Coverage

Secondary Research

Primary Research

Expert Panel Validation

Contact Us

Disclaimer

List of Tables

Prometheon Pharma, LLC, Key Facts

Prometheon Pharma, LLC - Pipeline by Indication, 2016

Prometheon Pharma, LLC - Pipeline by Stage of Development, 2016

Prometheon Pharma, LLC - Monotherapy Products in Pipeline, 2016

Prometheon Pharma, LLC - Combination Treatment Modalities in Pipeline, 2016

Prometheon Pharma, LLC - Preclinical, 2016

Prometheon Pharma, LLC - Discovery, 2016

Prometheon Pharma, LLC - Pipeline by Target, 2016

Prometheon Pharma, LLC - Pipeline by Route of Administration, 2016

Prometheon Pharma, LLC - Pipeline by Molecule Type, 2016

Prometheon Pharma, LLC - Pipeline Products by Mechanism of Action, 2016

List of Figures

Prometheon Pharma, LLC - Pipeline by Top 10 Indication, 2016

Prometheon Pharma, LLC - Pipeline by Stage of Development, 2016

Prometheon Pharma, LLC - Monotherapy Products in Pipeline, 2016

Prometheon Pharma, LLC - Pipeline by Target, 2016

Prometheon Pharma, LLC - Pipeline by Route of Administration, 2016

Prometheon Pharma, LLC - Pipeline by Molecule Type, 2016

Prometheon Pharma, LLC - Pipeline Products by Mechanism of Action, 2016
Note: Product cover images may vary from those shown
3 of 4

Loading
LOADING...

4 of 4
Note: Product cover images may vary from those shown
Adroll
adroll